I

ImmunoGenes AG

4 employees

ImmunoGenes is a biopharmaceutical company developing a platform which improves the immune system's response.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Anti-CB1 (Rabbit) Polyclonal Antibody
Genetically Modified Animal Development
Medical
Custom transgenic services
Anti-Insulin (Mouse) Monoclonal Antibody
Anti-CB1 (Mouse) Monoclonal Antibody
Custom antibody services
Antibody Discovery

Date founded

2007

Funding rounds raised

I

ImmunoGenes AG raised undisclosed on December 3, 2020

Investors: Texas HALO Fund

FAQ